Henner Hanssen Selected Research

Biological Products

1/2022

A 4-week high-AGE diet does not impair glucose metabolism and vascular function in obese individuals.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Henner Hanssen Research Topics

Disease

5	Hypertension (High Blood Pressure) 01/2022 - 03/2010
4	Obesity 01/2022 - 01/2011
3	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 01/2016
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 07/2019
3	Inflammation (Inflammations) 01/2022 - 08/2009
2	Pediatric Obesity 01/2021 - 01/2018
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2019 - 01/2019
2	Atherosclerosis 01/2019 - 08/2009
2	Heart Failure 01/2019 - 10/2009
2	Overweight 01/2018 - 01/2018
2	Necrosis 04/2017 - 02/2011
1	Pre-Eclampsia (Preeclampsia) 02/2022
1	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 02/2022
1	Hypertensive Retinopathy 01/2022
1	Insulin Resistance 01/2022
1	Cognitive Dysfunction 01/2022
1	Chronic Disease (Chronic Diseases) 01/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 04/2019
1	Depressive Disorder (Melancholia) 11/2018
1	Rheumatic Diseases (Rheumatism) 01/2018
1	Prehypertension 06/2016
1	Atrial Remodeling 01/2016
1	Stroke (Strokes) 03/2010

Drug/Important Bio-Agent (IBA)

11	Retinaldehyde (Retinal)IBA 11/2022 - 03/2010
7	Biomarkers (Surrogate Marker)IBA 11/2022 - 02/2011
3	Oxygen (Dioxygen)IBA 01/2020 - 01/2018
2	Advanced Glycation End ProductsIBA 01/2022 - 01/2020
2	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2020 - 07/2019
2	Sitagliptin Phosphate (Januvia)FDA Link 01/2020 - 07/2019
2	Clostridium perfringens epsilon-toxinIBA 01/2020 - 10/2009
1	Antihypertensive Agents (Antihypertensives)IBA 02/2022
1	LipidsIBA 01/2022
1	Biological ProductsIBA 01/2022
1	Dietary Advanced Glycation End ProductsIBA 01/2022
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2021
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2020
1	PlacebosIBA 01/2020
1	tocilizumab (atlizumab)FDA Link 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 07/2019
1	Glucagon-Like Peptide 1 (GLP 1)IBA 07/2019
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	Mydriatics (Cycloplegics)IBA 01/2019
1	C-Reactive ProteinIBA 04/2017
1	Cartilage Oligomeric Matrix ProteinIBA 04/2017
1	Interleukin-6 (Interleukin 6)IBA 04/2017
1	MicroRNAs (MicroRNA)IBA 01/2016
1	CytokinesIBA 01/2011
1	oxidized low density lipoproteinIBA 08/2009

Therapy/Procedure

2	Endurance Training 01/2022 - 04/2017
2	Resistance Training 01/2022 - 01/2015
1	Renal Dialysis (Hemodialysis) 01/2022